Additions to Methotrexate with Conventional and Biologic DMARDs in Rheumatoid Arthritis: Are there Difference in Subsequent Time to Treatment Failure?

被引：0
|
作者：
Moura, Cristiano [1 ]
Bykerk, Vivian [2 ]
Schieir, Orit
Valois, Marie-France [3 ]
Bartlett, Susan [3 ]
Hitchon, Carol [4 ]
Pope, Janet [5 ]
Boire, Gilles [6 ]
Haraoui, Boulos [7 ]
Keystone, Edward [8 ]
Tin, Diane [9 ]
Thorne, Carter [9 ]
Bernatsky, Sasha [10 ]
机构：
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[2] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[3] McGill Univ, Montreal, PQ, Canada
[4] Univ Manitoba, Winnipeg, MB, Canada
[5] Western Univ, Dept Med, Div Rheumatol, London, ON, Canada
[6] Univ Sherbrooke, Sherbrooke, PQ, Canada
[7] Inst Rhumatol Montreal, Montreal, PQ, Canada
[8] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada
[9] Southlake Reg Hlth Ctr, Newmarket, Suffolk, England
[10] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2018年 / 45卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
92
引用
收藏
页码：1004 / 1004
页数：1
相关论文
共 50 条
  • [1] Additions to Methotrexate with Conventional and Biologic Dmards in Rheumatoid Arthritis: Are There Differences in Subsequent Time to Treatment Failure?
    Bernatsky, Sasha
    Schieir, Orit
    Moura, Cristiano S.
    Valois, Marie-France
    Bartlett, Susan J.
    Hitchon, Carol A.
    Pope, Janet E.
    Boire, Gilles
    Haraoui, Boulos
    Keystone, Edward C.
    Tin, Diane
    Thorne, Carter
    Bykerk, Vivian P.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis
    Sung, Yoon-Kyoung
    Cho, Soo-Kyung
    Kim, Dam
    Choi, Chan-Bum
    Won, Soyoung
    Bang, So-Young
    Cha, Hoon-Suk
    Choe, Jung-Yoon
    Chung, Won Tae
    Hong, Seung-Jae
    Jun, Jae-Bum
    Kim, Hyoun Ah
    Kim, Jinseok
    Kim, Seong-Kyu
    Kim, Tae-Hwan
    Lee, Hye-Soon
    Lee, Jaejoon
    Lee, Jisoo
    Lee, Shin-Seok
    Lee, Sung Won
    Lee, Yeon-Ah
    Nah, Seong-Su
    Suh, Chang-Hee
    Yoo, Dae-Hyun
    Yoon, Bo Young
    Bae, Sang Cheol
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (06) : 975 - 982
  • [3] Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis
    Yoon-Kyoung Sung
    Soo-Kyung Cho
    Dam Kim
    Chan-Bum Choi
    Soyoung Won
    So-Young Bang
    Hoon-Suk Cha
    Jung-Yoon Choe
    Won Tae Chung
    Seung-Jae Hong
    Jae-Bum Jun
    Hyoun Ah Kim
    Jinseok Kim
    Seong-Kyu Kim
    Tae-Hwan Kim
    Hye-Soon Lee
    Jaejoon Lee
    Jisoo Lee
    Shin-Seok Lee
    Sung Won Lee
    Yeon-Ah Lee
    Seong-Su Nah
    Chang-Hee Suh
    Dae-Hyun Yoo
    Bo Young Yoon
    Sang Cheol Bae
    Rheumatology International, 2017, 37 : 975 - 982
  • [4] Tapering biologic DMARDs in rheumatoid arthritis
    Braverman, Genna
    Bridges, S. Louis
    Moreland, Larry W.
    CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2022, 61
  • [5] UNAFFORDABLE CONVENTIONAL AND ABSENT BIOLOGIC DMARDS: INCREASING THE BURDEN OF RHEUMATOID ARTHRITIS IN FYROM
    Georgjieva, O.
    Memeti, N.
    Damjanovska-Krstikj, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 280 - 280
  • [6] Cancer risk with biologic DMARDs in rheumatoid arthritis
    Reactions Weekly, 2017, 1672 (1) : 11 - 11
  • [7] THE COST-EFFECTIVENESS OF BIOLOGIC DMARDS IN PATIENTS WITH SEVERE OR MILD-TO-SEVERE RHEUMATOID ARTHRITIS AFTER CONVENTIONAL DMARDS
    Wailoo, A. J.
    Stevenson, M.
    Tosh, J.
    Hernandez, M.
    Stevens, J. W.
    Archer, R.
    Simpson, E.
    Hock, Everson E.
    Scott, D.
    Young, A.
    Paisley, S.
    Williams, K.
    VALUE IN HEALTH, 2014, 17 (07) : A380 - A380
  • [8] Rheumatoid Arthritis and the Risk for Interstitial Lung Disease: A Comparison of Risk Associated with Biologic and Conventional Dmards
    Xie, Fenglong
    Annapureddy, Narender
    Chen, Lang
    Lobo, Jason Leonard
    Oates, Jim C.
    Shah, Ankoor
    Yun, Huifeng
    Yang, Shuo
    Curtis, Jeffrey R.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [9] BIOLOGIC DMARDS TREATMENT RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO THE MOSCOW ARTHRITIS REGISTRY (MERA)
    Koltsova, E.
    Zhilyaev, E.
    Lukina, G.
    Shmidt, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1379 - 1379
  • [10] Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate
    Koyama, Yoshinobu
    Shiraishi, Hirokazu
    Ohta, Toshiyuki
    Uchino, Ayumi
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 100 - 108
12345